Abstract: Over the past decade, significant progress has been made in the identification of novel material binding peptides having affinity to a wide range of target materials and their use in nanobiotechnological innovations. These material binding peptides (MBPs), also known as solid/ substance binding peptides (SBPs) can be isolated using combinatorial display technologies such as phage display (PD), surface display (cell, bacterial, yeast, mRNA) exhibit material specific selectivity and affinity towards a range of inorganic and organic nanomaterial surfaces including metals, metal oxides, minerals, semiconductors and biomolecules. MBPs serve as mediators in bringing nanotechnology and biotechnology under one umbrella by linking solid nanoparticles with biomolecules including proteins, bioactive peptide motifs, bifunctional binding peptides, enzymes, antigens and antibody fragments. As the utilization and application of these inorganic binding peptides as molecular connectors, molecular assemblers and material specific synthesizers in nanotechnology has been expanding rapidly, so too has growing commercial interest in patenting such innovations. In this review, we present the past, current and future developments and applications of inorganic MBPs specific to nanomaterials and their applications.
INTRODUCTION
MBPs have attracted considerable interest in the development of innovative nanostructured materials in particular because of their promising and growing applications in nanotechnology. These MBPs are also called inorganic binding peptides (IOBPs) or substrate binding peptides (SUBPs) or solid binding peptides (SBPs) or genetically engineered peptides for inorganics (GEPIs). MBPs are short amino acid peptide sequences that are genetically constructed and show specific affinity to a target material through combinatorial display approaches which include phage display [1] [2] [3] [4] [5] [6] , cell surface display [7] [8] [9] [10] , ribosome display [11] [12] [13] [14] and mRNA display [15] [16] [17] [18] technologies. Although nanomaterials have been designed and produced decades ago, their utilization in nano-or biotechnology is limited due to poor solubility and biocompatibility issues. However, several strategies have been developed to overcome the potential safety concerns and eventually, peptide display technologies came into existence by managing greater control over the nanomaterials without compromising their physical, chemical and functional properties.
G.P Smith, for the first time used phage display technology as a powerful tool to identify ligands for numerous targets in 1985 [1] . From there on, phage or cell surface displayed (7-15mers) libraries have become ubiquitous in selecting and screening peptides having strong *Address correspondence to this author at the Interdisciplinary Biomedical Research Centre, Nottingham Trent University, Clifton Lane, NG11 8NS, Nottingham, UK; Tel: +44-115-8486695; E-mail: Carole.Perry@ntu.ac.uk affinity towards a range of inorganic material surfaces such as metals (Ag [19] [20] [21] , Au [22, 23] , Pt [24] , Pd [25] ), metal oxides (SiO2 [26] [27] [28] [29] [30] , ZnO [31, 32] , TiO2 [33] [34] [35] , Fe2O3 [36, 37] , IrO2 [38] , Al2O3 [24, 39] , Cu2O [31] ), minerals (calcite, hydroxyapatite, graphite, mica, sapphire) [40] [41] [42] , semiconductors (CdS, GaN, GaAs and ZnS) [43] [44] [45] , carbon materials (graphene, carbon nanotubes) [46, 47] and polymer materials [48, 49] . These isolated peptides have many practical applications in biomineralization [32, 50, 51] , synthesis and fabrication of inorganic nanomaterials [40, [52] [53] [54] [55] [56] [57] [58] , immobilization of nanoparticles onto inorganic or organic surfaces and surface functionalization [34, 38, [59] [60] [61] . Now, it is starting to be possible to create novel materials using biological linkers to join more than one type of material generating hybrids with unique electronic, mechanical, magnetic or photonic properties [26, 27] .
The aim of this paper is to summarize and discuss recent progress in patents on MBPs specifically exploring inorganic nano surfaces like metals, metal oxides, minerals, carbon based materials, polymer based materials, magnetic materials and semiconductors by peptide display strategies and their utilization in the generation of advanced nanomaterials.
In order to get a clear picture on the number of patents present to date relevant to MBPs and their applications, a thorough online search was conducted using the available free national and worldwide databases which include EPO Espacenet, WIPO patent scope, USPTO, Google patent search, Patent lens etc. along with commercial databases including Derwent and Patbase. The key words used to find all the relevant patents were combinatorial/ phage displayed
COMBINATORIAL DISPLAY PROCESS ON NANOMATERIAL SURFACES
The connection between inorganic materials and biomolecules is not new in nature and exists naturally through the process of biomineralization. Through this, complex inorganic nanostructures including metal oxides and minerals are synthesized by certain species like magnetite, an iron oxide (Mms Proteins) in bacteria [62] [63] [64] , silica (silaffins) in diatoms [65] [66] [67] [68] [69] [70] , silica (silicatein) in sponges [71, 72] aragonite and calcite (chitin, proteins and polysaccharides) in mollusks [73] . Though artificial processes have been used to reproduce the biominerals or materials their quality is challenging. In order to meet the quality and demand, several research groups started their quest for better alternate routes to produce more efficient, reliable and bulk bionanomaterials using inspiration from nature. This lead to the discovery of novel biomimetic approaches where peptides having affinity towards any target inorganic material can be isolated and practically reproduced using combinatorial peptide libraries such as phage display [1] [2] [3] [4] [5] [6] , bacterial/ yeast display [7] [8] [9] [10] , ribosome, mRNA or cDNA display [11] [12] [13] [14] [15] [16] [17] [18] and rational design [74] [75] [76] as shown in Figure 1 . A combinatorial phage library consists of peptide, protein and antibody libraries many of which are commercially available. These libraries have been constructed by fusing DNA fragments into the genome of the phage or phagemid, and displaying the peptides on the surface of the phage coat proteins. For example, different types of phage coat proteins including pIII, pVI, pVII, pVIII and pIX have been used in phage libraries to display peptides, proteins and antibodies. as shown in Figure 1 . The selection of coat proteins in the phage library depends on the type of display being looked for. For example, pIII phage capsid protein allows for monovalent display while pVIII allows for polyvalent display. A typical combinatorial display approach involves selection, screening and recovery of MBPs using any of the mentioned combinatorial technologies. So far, a range of biomimetic peptides showing specific affinity and molecular recognition for inorganic nanomaterials including metals, metal oxides, minerals, magnetic and semiconductor materials, carbon or polymer based materials have been isolated . Further, these material specific peptides have been used for synthesizing simple to complex bio-or nano-materials, mediating the controlled biomineralzation process, directing self-assembly and nanofabrication of ordered structures, facilitating the immobilization of functional biomolecules and for constructing inorganicinorganic or organic-inorganic nano hybrids [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [77] [78] [79] .
RECENT PATENTS ON INORGANIC MBPS AND THEIR APPLICATIONS
This section summarizes relevant patents on inorganic MBPs and their application towards novel innovations as shown in Tables 1-6 . In the patents (WO 078451 A2, US 7905943 B1, US 0172282 A1) Naik and coworkers [80, 81] , used the phage display technique to screen and isolate MBPs specific to metals (Ag, Au, Co, Pd, Gd), metal oxides (SiO2, GeO2, Co3O4, Fe2O3, ZnO, SnO2) and other materials (ruby, carbon nanotubes). These peptides were further used as templates to mediate the controlled synthesis and formation of useful nanostructured materials alongside producing multifunctional bimetallic (gold-palladium) hybrid nanomaterials [81] . In addition to the existing combinatorial phage display approach for identifying novel peptides that are capable of showing high binding to inorganic surfaced nanomaterials, they developed a polymerase chain reaction (PCR)-driven phage display method to isolate peptide sequences specific to nanomaterials, thereby improving the process [82] .
In a similar way, many patents have been registered obtaining SBPs having binding affinity towards a range of metals and metal oxides such as gold [83] , silver, titanium and silicone [84] , silica coated particles [85] , titanium oxide and silicon containing compounds [86] , titanium and stainless steel [87] , iron oxide [88] , dysprosium oxide [89] and ceramic materials [90] that utilize the same peptide sequences to initiate and synthesize nanostructures by tuning their size and shape [91] . Also, peptides designed through biomimetic and computational modelling have been used to precipitate stable and well defined titanium oxide nanoparticles of uniquely controlled morphologies including rectangular (KSSKK), spherical (SKSKKKSKSKKK, SKKKKKKKKKS, RRSSSRRSSSRR, RRRSRRRSRRRSRRR and SKKSKKK), flat and fused disks (SKKKKSSKKKKS, KKKSKSKKK, RRRSSRRRSSRRR, SKSKKKSKSKKKSKS and SSKKKSSKKK) and porous sheets (SKKKKKSKKKK, KKSSKKKKKKKKKS, KKKKSSKKKK, SKKSKKKKKKKK and SKKKSKKKK) without the use of high temperatures and pressures [92] . Additionally, these peptides revealed aggregate formation among themselves and the role of secondary structure in controlling morphology [92] . Vreuls et al. invented a method to identify imperfections or non-homogenous conditions on the surface of materials thereby isolating specific nanoparticles from a mixture by using stainless steel (MTWDPSLASPRS), titanium oxide (LNAAVPFTMAGS) and zinc oxide binding peptides (VRTRDDARTHRK) [93] . In a separate patent (US 0219504 A1), Cho and co-workers created a complex protein joining zinc oxide binding peptides and zinc oxide nanoparticles together which resulted in an active agent for delivering drugs in vivo by an intracellular mode and helping in cell or MRI imaging [94] . In another patent (US 0249682 A), Williams and co-workers disclosed a sunscreen formulation that is resistant to water and lasts for a long time using peptide derived oxides such as titanium dioxide, zinc oxide, iron oxide, cerium oxide and a combination of nanoparticles alongside liquid as a sunscreen agent [95] .
Desmond Mascarenhas in his patent (WO 056511 A2) described a method for treating selective human inflammatory diseases by delivering the metallic binding domain polypeptide linker complex (QCRPSKGRKRGFCW) in conjunction with curcumin and lycopene that showed specific binding to live cells that were under cellular stress resulting in increased cellular uptake, providing diagnostic information and altering a wide range of disease and cellular processes [96] . Alternatively, functionalised biomolecules were produced in cells or organisms by incorporating materials such as metals, toxins and peptides into the genome of cells and such modified cells have been used for isolating targeted molecules within the cells [97] . Furthermore, Krauland et al. (WO 079053 A2) engineered two peptides (GKGKGKGKGKGK & GKGKGKGKGKGKASGKGKGKGKGKGK) using a combination of yeast surface display, biopanning approaches, rational design strategy and genetic engineering that exhibit high affinity to metal oxide surfaces (eg. sapphire, quartz etc.) and bind in a reversible manner to plasma activated surfaces (eg. polystyrene, polydimethylsiloxane, polyurethane etc. upon exposure to oxygen plasma) where either of the peptides can selectively be released by exposing the oxide or plasma activated surfaces to high salt conditions and/or changing the electric field. In addition, these peptides when integrated selectively with protein or cells, act as a binding agent towards targeted oxide surfaces, thereby helping in the construction of biosensors [98] .
Imamura et al. disclosed an invention related to a magnetic-biosubstance complex structure formation, where the biosubstance was immobilized on the carrier present on the magnetic substance. As a result of this, structures containing a carrier can be used as a vehicle for carrying or delivering diagnostic agents, bacteria, cells and drugs, separation and purification of proteins, DNA or RNA, as a carrier for enzyme reaction and for the formation of complex structures could be developed. The structure in the present invention (WO 097416 A1) comprises a magnetic substance, a peptide fragment and/or a gene capable of linking to a magnetic substance, preferably ferrous oxide (Fe2O3) binding peptides selected from phage display and a biosubstance containing nucleic acids, proteins, lipids, carbohydrates and combinations thereof, preferably a polyhydroxyalkanoatesynthesizing enzyme [99] . [100] , controlled nanoparticle synthesis including the desired target nanoparticle size, shape, growth and crystal phase by using the same phage or virus displayed nanoparticle binding peptides [101] and directing the assembly and fabrication of magnetic or semiconducting nanoscale hybrid materials mediated by genetically engineered mesoscale virus or phage displayed peptides [102, 103] . Additionally, these peptide or virus equipped multifunctional biomaterials have been used as templates or scaffolds for magnetic, electronic, optical and semiconducting applications [104] , as well as for designing biofilm storage devices and nanowires [105, 106] . All the patents from this group describe a range of phage displayed or virus modifications that show specific binding to nanomaterial structures, as well as forming novel hybrid structures in the presence of modified biomaterials for specific binding. For instance, the polypeptide and oligomeric amino acid sequences can be expressed anywhere on the surface of the virus particles or coat proteins including pIII, pVI, pVII, pVIII and pIX and in the genome of the virus itself or at more than one site for modification of specific binding units. i.e. the ends of the polypeptide or virus particle can be altered to show specific recognition to an initial target material, whereas the genome of the virus can be manipulated to show specific affinity towards a second target material. In this process, multiple sites on the virus nanoparticles can be modified and utilized as scaffolds or templates for designing nanowires and novel devices [100] [101] [102] [103] [104] [105] [106] .
Carbon based MBPs include graphene, fullerene and single or multi-walled carbon nanotubes. In separate inventions, two separate patents (US 0309126 A1 and WO 102020 A2) were issued for selecting peptides that were found to have specific binding interaction for a variety of graphitic materials such as graphene, highly oriented pyrolytic graphite, graphite alone and fullerenes [107] and for carbon nanotubes [108] . Moreover, these graphitic or carbon nanotube binding peptides have been used for application towards designing sensing devices to detect microorganisms. For example, a method for preparing sensors has been disclosed (US 0156688 A1), in which the sensing device was built by immobilising the antimicrobial peptide motifs having definite binding affinity for targets including E.coli, gram +ve or -ve bacteria, viruses, pathogens, fungi and varied cancer cells which can be read out upon changes in the electrical conductivity of the system [109] . Similarly, mineral based MBPs for clay, calcium phosphate or calcium carbonate, hydroxyapatite and other materials have been identified. A number of patents were granted for peptides having specific binding affinity for a variety of minerals including clay [110] , calcium carbonate [111] and hydroxyapatite materials [112] [113] [114] . Additionally, these mineral recognising peptides have been utilized for regenerating or inhibiting the growth of bone under controlled biomineralization conditions [112] and for curing dental diseases [112] . For example, Bertozzi ed. filed a patent for the identification of hydroxyapatite binding peptides which are similar to the type I collagen sequence (Gly-Pro-Hyp)X, a crucial material of extracellular matrices of native bone; with these sequences then being used as a template for synthesizing implantable bone by attaching a biocompatible and biodegradable substrate in mammals [112] . In contrast, Sarikaya et.al. developed a method for curing dental diseases and initiated dental mineralisation by constructing a recombinant polypeptide complex comprising phage displayed amelogenin and heterologous polypeptide containing substances derived from collagen, dentin, statherin, osteocalcin, enamilin and/or inorganic polypeptides and their affinity tags and markers [113] . In another patent (US 0070200 A1), he described a method and system for developing polypeptides which were initially characterized based on their specific affinities, physical and chemical properties for target inorganic substances and then applied those characterizations computationally to generate a polypeptide-scoring function resulting in the identification of further polypeptide sequences for additional applications in areas such as electronics, nanomedicine and nanotechnology [114] . [87] , polypyrrole doped with chlorine and poly lactic acid-co-glycolic acid [115] , phenolic compounds [116] , polyethylene [117] , polymethylmethacrylate [118] , poly (benzyl methacrylate-co-methacrylic acid) potassium salt copolymers [119] and polycarbonate and polyurethane surfaces [120, 121] . Moreover, these polymer binding peptides along with proteins of bacteriophages have been utilized for the prolonged release of drugs [120] and as an active coating material for developing corrosion resistant surfaces [121] . In the same way, a separate class of MBPs were also reported where one or more compounds binds to different specific targets under the presence of anti-targets. In simple terms, a peptide that binds specifically to compound A has been identified using compound B as an anti-target and compound B binding peptides in the presence of anti-target compound A. The compounds include coloring, conditioning, cosmetic and personal care reagents that are directly involved in improving the properties of keratin, a key component in skin, hair, nails and teeth. Various patents have been published where peptides having higher affinity for human body surfaces such as skin, hair, nail, teeth, pigment, gum or oral cavity; nylon agent and fluorophore dyes were selected and identified using phage, ribosome and mRNA libraries [122] [123] [124] [125] [126] [127] [128] [129] [130] . Although peptide based products have useful applications, their long lasting behavior remains a challenge. In order to improve the durability for these products, two or more agent binding peptides have been used alongside linkers [123] [124] [125] [126] [127] . Further, these body surface binding proteins or peptides have been used in day to day applications such as hair or nail coloring reagents [123] , conditioners for hair or skin [124] , personal care products for skin, teeth and associated pigments [125] , as cosmetic delivery agents [126] , recombinant peptide production [127] and for developing markers, fragrances, pharmaceutical products, selective fabrics and fluorophore dyes [128] [129] [130] .
CONCLUSION
Biomimetic MBPs have emerged as a new frontline in the design of novel nanomaterials with improved/ controlled physical and chemical properties without affecting the structural or functional activities of the nanomaterials themselves which can be realized from the above discussion of recent literature and patents. Although combinatorial display technologies are firstly for selecting and identifying biomolecules against almost any material of interest and further towards generating more efficient and reliable peptide based nanostructures, the accuracy of molecular recognition for inorganic materials as a target and then translating practical (in vitro, in vivo or ex vivo and in silico) applications into product specific commercial success is still challenging unlike the situation where organic molecules are the targets of interest.
CURRENT & FUTURE DIRECTIONS
The unique binding ability/nature of peptide libraries to select and screen specific material of interest, particularly inorganic materials has created much interest and potential to reach a wider scientific community which may ultimately lead to the development of even more novel bio-or nanomaterials. However, these libraries still possess drawbacks. These include their ability to bind to non-specific undesired targets [131, 132] , under representation of the desired sequences and their properties due to having bias towards peptide/ protein position, composition, and expression [133] or pH and interaction specific intrinsic bias [30] , thus many target specific strong MBPs are not found during the phage display process. Additionally, another important factor to consider is the limited fundamental understanding of peptide-material interactions which is a major bottle neck for generating peptide based inorganic nanomaterials with improved biostability/ compatibility, solubility and functionality and increased physico-chemical properties. In advancing our understanding of peptide mineral interactions a clear understanding of the solution behavior of both the peptide and the mineral is needed before the interaction of the two can be understood. As examples, in our research we have shown that by careful study of the particular properties of the material itself, for example silica [29, 30, 134] and ZnO [57, 135, 136] we can show that the size of particles [29, 30, 134] and charge/ functionality on particles [30, 137] have clear effects on the binding of small peptides to minerals as well as the route by which a material is formed [57, 135, 136] by moderating peptide mineral interaction.
Further, although, online databases are easily available for specific organic MBPs such as antimicrobial and anticancer peptides, no specific databases have been designed for inorganic MBPs obtained from distinct classes of combinatorial display techniques. We propose that such databases, with all the experimental and computational information relating to the different classes of nanomaterials and libraries should be built. These databases will find solutions for bias problems and improve our understanding of biomolecule-inorganic material interactions which will lead in turn to the development of smart nanomaterials and slowly reduce the sole dependence on in vitro display technologies to take this approach forward as is presently the case. 
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